Heart valve disease represents a diverse spectrum of conditions that pose significant challenges to cardiovascular health. While some cases of valve disease may remain asymptomatic for a long time, others can progress to severe complications, including heart failure. The management of heart valve disease often involves a collaborative effort among cardiologists, cardiac surgeons, and other healthcare professionals. Advances in medical technology have led to the development of less invasive procedures, such as transcatheter aortic valve replacement (TAVR), providing viable options for certain patients who may not be suitable candidates for traditional open-heart surgery. Ongoing research aims to enhance our understanding of the underlying mechanisms of valve disease and explore novel therapeutic approaches. Regular monitoring, early intervention, and personalized treatment plans are crucial elements in the comprehensive care of individuals with heart valve disease, emphasizing the importance of a multidisciplinary and patient-centered approach in addressing the complexities of this cardiovascular condition.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain